ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD)
Public ClinicalTrials.gov record NCT03362190. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2A Open-label Trial to Assess the Safety of ZIMURA™ (Anti-C5) Administered in Combination With LUCENTIS® 0.5 mg in Treatment Naive Subjects With Neovascular Age Related Macular Degeneration
Study identification
- NCT ID
- NCT03362190
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Ophthotech Corporation
- Industry
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Interventions
- Avacincaptad Pegol Drug
- Lucentis Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 10, 2017
- Primary completion
- Oct 17, 2018
- Completion
- Oct 17, 2018
- Last update posted
- Jun 9, 2025
2017 – 2018
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retinal Research Institute | Phoenix | Arizona | 85053 | — |
| Retina Centers PC | Tucson | Arizona | 85704 | — |
| Retina Associates SW, PC | Tucson | Arizona | 85710 | — |
| Retina-Vitreous Associates Medical Group | Beverly Hills | California | 90211 | — |
| Retina Consultants of Orange County | Fullerton | California | 92835 | — |
| Retina Consultants of Southern California | Redlands | California | 92374 | — |
| Retinal Consultants Medical Group | Sacramento | California | 95841 | — |
| Orange County Retina Medical Group | Santa Ana | California | 92705 | — |
| Colorado Retina Associates | Golden | Colorado | 80214 | — |
| Florida Eye Clinic | Altamonte Springs | Florida | 32701 | — |
| Florida Eye Associates | Melbourne | Florida | 32901 | — |
| Illinois Eye Center | Peoria | Illinois | 61615 | — |
| Vitreo Retinal Consultants & Surgeons | Wichita | Kansas | 67214 | — |
| Ophthalmic Consultants of Boston | Boston | Massachusetts | 02114 | — |
| VitreoRetinal Surgery | Minneapolis | Minnesota | 55435 | — |
| Retina Consultants of Nevada | Henderson | Nevada | 89052 | — |
| Sierra Eye Associates | Reno | Nevada | 89502 | — |
| Retina Vitreous Surgeons of CNY, PC | Syracuse | New York | 13224 | — |
| Retina Northwest PC | Portland | Oregon | 97221 | — |
| Mid Atlantic Retina | Philadelphia | Pennsylvania | 19107 | — |
| Charleston Neuroscience Institute | Ladson | South Carolina | 29456 | — |
| Retina Research Institute of Texas | Abilene | Texas | 79606 | — |
| Strategic Clinical Research Group | Willow Park | Texas | 76087 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03362190, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 9, 2025 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03362190 live on ClinicalTrials.gov.